A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus

preprint OA: closed
📄 Open PDF Full text JSON View at publisher
Full text 99,890 characters · extracted from preprint-html · click to expand
A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus Eden G. TenBarge , Ashley D. Wise , Morgan L. Hetzel , Helene A. Hoover , Helia Esfandiari , Bailey E. Holder , Eva Belevska , Ellie C. Mennen , Sarah R. McDaniel , Nicole M. Vaccaro , Courtney C. Lucca , Jonathan M. Williams , Jennifer Ferris , Timothy E. Sparer , Leslie J. Crofford , Jeffry D. Bieber , Andrew J. Monteith doi: https://doi.org/10.1101/2025.10.07.680928 Eden G. TenBarge 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ashley D. Wise 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Morgan L. Hetzel 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Helene A. Hoover 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Helia Esfandiari 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bailey E. Holder 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eva Belevska 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ellie C. Mennen 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sarah R. McDaniel 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Nicole M. Vaccaro 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Courtney C. Lucca 2 Division of Rheumatology, University of Tennessee Medical Center , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jonathan M. Williams 3 Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center , Nashville, TN Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jennifer Ferris 2 Division of Rheumatology, University of Tennessee Medical Center , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Timothy E. Sparer 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Leslie J. Crofford 3 Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center , Nashville, TN 4 Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center , Nashville, TN Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jeffry D. Bieber 2 Division of Rheumatology, University of Tennessee Medical Center , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Andrew J. Monteith 1 Department of Microbiology, University of Tennessee , Knoxville, TN, USA 5 Department of Biochemistry & Cellular and Molecular Biology, University of Tennessee , Knoxville, TN, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: amonteit{at}utk.edu Abstract Full Text Info/History Metrics Supplementary material Preview PDF Abstract Patients with systemic lupus erythematosus (SLE) are susceptible to bacterial infections, but the underlying dysfunction remains unclear. We found that Staphylococcus aureus triggers mitochondria-dependent suicidal NETosis via lactate sensing in healthy neutrophils, but this response is defective in SLE. Herein, we show that chronic Toll-like receptor (TLR) 7/9 signaling represses mitochondrial lactate dehydrogenase B (LDHB), thereby impairing lactate sensing and downstream suicidal NETosis. Instead, SLE neutrophils default to vital NET release; a less bactericidal, type I interferon (IFN)-driven process amplified by staphylococcal pore-forming toxins and sustained by elevated systemic IFNα levels observed in SLE. Combined treatment with hydroxychloroquine (HCQ) and interferon-alpha/beta receptor (IFNAR) blockade restores LDHB expression, NET homeostasis, and bacterial clearance in lupus-prone mice. Neutrophils from SLE patients exhibit similar defects, which are reversed by HCQ and the IFNAR-blocking antibody anifrolumab. These findings identify a clinically actionable immunometabolic checkpoint linking chronic autoimmune signaling to defective antibacterial defense in SLE. Introduction Neutrophils are critical for controlling microbial pathogens such as Staphylococcus aureus. However, their inflammatory responses must be tightly regulated to balance effective pathogen clearance with host tissue protection. A hallmark of this balance is the formation of neutrophil extracellular traps (NETs), which trap and kill S. aureus 1 – 4 , prevent bacterial dissemination 1 , 5 , and enhance macrophage activation 6 – 8 . However, NETs can also drive pathology by exposing nuclear antigens and pro-inflammatory mediators, contributing to autoimmune responses. In systemic lupus erythematosus (SLE), excessive NET deposition is widely reported and thought to perpetuate disease by promoting type I interferon (IFN) production 9 – 11 , autoantibody generation 12 , 13 , endothelial damage 14 – 16 , thrombosis 17 , 18 , and cardiovascular disease 19 , 20 . Impaired NET clearance due to DNase deficiencies 21 – 23 or defective lysosomal degradation by macrophages 24 – 26 exacerbates these effects, prolonging local inflammation. Human studies similarly associate NET abundance with disease activity in SLE 27 – 29 , suggesting that dysregulated NET formation and clearance are central to SLE pathology. NETs are composed of decondensed chromatin decorated with antimicrobial proteins. Functionally, two mechanistically distinct forms exist: suicidal NETosis, in which NETs are released through lytic cell death 2 , and vital NET release, where chromatin is extruded without compromising membrane integrity 3 . Suicidal NETosis has historically been attributed to NADPH oxidase-derived reactive oxygen species (ROS) 30 , 31 , but recent studies highlighted a role for mitochondrial ROS as an essential trigger, particularly during responses to bacteria 7 , 32 – 34 and in the autoimmune setting of SLE 10 , 35 . In contrast, vital NET formation is ROS-independent and can be triggered by microbial toxins 3 or IFNα 36 , although its regulation remains poorly understood. Despite the differences in regulation, both suicidal and vital NET release require the citrullination of histones by protein arginine deiminase 4 (PAD4) to promote DNA decondensation 37 . Despite their heightened tendency to release NETs, neutrophils from SLE patients fail to undergo mitochondrial ROS-dependent suicidal NETosis in response to S. aureus 34 , 38 . Neutrophils are metabolically unique in that they rely primarily on glycolysis for energy 39 – 43 , yet they retain functional mitochondria 44 , 45 . We previously demonstrated that mitochondrial sensing of phagosomal lactate, a byproduct of S. aureus fermentation, acts as a critical danger signal that triggers mitochondrial ROS production and initiates suicidal NETosis 34 . In SLE, however, neutrophils exhibit altered mitochondrial homeostasis that impairs this pathway, defaulting instead to chronic vital NET release 34 , 38 . This paradox suggests that excessive NET formation in SLE may arise from dysregulated mechanisms that favor non-lytic, and potentially less effective, NET programs. This dysregulation may underlie the increased risk of severe bacterial infections in individuals with SLE 46 – 49 . However, the signaling pathways linking chronic inflammation in SLE to altered neutrophil NET programs remain incompletely understood. Herein, we identify a critical immunometabolic mechanism by which Toll-like receptor (TLR) 7 and TLR9 signaling represses mitochondrial lactate dehydrogenase B (LDHB) expression in neutrophils, thereby preventing lactate sensing and impairing suicidal NETosis in response to S. aureus . Instead, these neutrophils default to vital NET release, a less bactericidal response that is sustained by pore-forming toxins from S. aureus and IFNα-driven autocrine signaling. This aberrant NET program is reversed by hydroxychloroquine (HCQ) and interferon-alpha/beta receptor (IFNAR) treatment in lupus-prone mice, restoring LDHB expression, mitochondrial ROS production, and bacterial clearance. Importantly, neutrophils from SLE patients exhibit similar defects in LDHB expression and NET regulation, which are largely corrected by HCQ and IFNAR1-blocking antibody, anifrolumab. These findings reveal a clinically actionable immunometabolic axis linking chronic innate immune activation to defective neutrophil antibacterial responses in SLE. Results TLR7/9 signaling diminishes LDHB expression and prevents suicidal NETosis in response to S. aureus We previously demonstrated that reverse conversion of staphylococcal lactate into pyruvate in the mitochondria is essential for triggering mitochondrial ROS and initiating suicidal NETosis 34 . Mammalian cells express two distinct isoforms of LDH: LDHA, which catalyzes the conversion of pyruvate to lactate during glycolysis, and LDHB, which preferentially converts lactate back into pyruvate and associates with mitochondria 50 – 52 . In line with this, we previously found that mitochondria from SLE neutrophils exhibit reduced LDH activity, specifically, a diminished capacity to convert lactate to pyruvate, compared to healthy controls 34 . Therefore, loss of LDHB in SLE neutrophils may impair sensing of phagosomal lactate from S. aureus , which would compromise suicidal NETosis. To investigate this, we used MRL/MpJ- Tnfrs6 lpr /J (MRL/ lpr ) mice, a well-established murine model of SLE that recapitulates key autoimmune features of the human disease 53 . Neutrophils were isolated from MRL/ lpr and wild-type (WT) C57BL/6 mice, and expression of LDHA and LDHB was assessed by flow cytometry. MRL/ lpr neutrophils expressed significantly lower levels of LDHB compared to WT, whereas LDHA levels remained unchanged ( Fig. 1A , S1A). LDHB mRNA levels were comparable between WT and MRL/ lpr neutrophils ( Fig. 1B ), suggesting that LDHB is regulated post-transcriptionally. Consistent with this, mitochondrial fractions from MRL/ lpr neutrophils also showed reduced LDHB protein abundance by immunoblot ( Fig. 1C ), indicating loss of mitochondrial LDHB We previously reported that WT neutrophils undergo mitochondrial ROS–dependent suicidal NETosis in response to S. aureus , whereas MRL/ lpr undergo suicidal NETosis in response to apoptotic debris, indicating distinct and potentially antagonistic NET programs 34 . To explore upstream drivers of this divergence, we stimulated WT and MRL/ lpr neutrophils for 2 hours with agonists for TLR2/1, TLR2/6, TLR3, TLR4, TLR7, and TLR9 in the presence or absence of exogenous lactate. Mitochondrial ROS production and suicidal NETosis were quantified by flow cytometry as previously described 7 . WT neutrophils generated robust mitochondrial ROS ( Fig. 2A , S1B) and underwent suicidal NETosis ( Fig. 2B , S1C) in response to TLR2 and TLR4 agonists (Pam2CSK4, Pam3CSK4, and LPS) when lactate was present, consistent with their role in bacterial sensing. In contrast, MRL/ lpr neutrophils responded to TLR7 and TLR9 agonists (IMQ and CPG ODN) with lactate-independent suicidal NETosis, suggesting a shift in NETosis programming. Download figure Open in new tab Figure 1: LDHB expression is suppressed in neutrophils from lupus-prone mice. ( A-B ) Neutrophils were isolated from WT or MRL/ lpr and ( A ) total LDHA or LDHB protein were quantified by flow cytometry relative to an isotype control antibody or ( B ) LDHA or LDHB transcript quantified relative to ACTB by quantitative PCR. ( C ) Mitochondria were isolated from WT or MRL/ lpr neutrophils and the abundance of LDHB or the mitochondrial superoxide dismutase 2 (SOD2) were quantified by immunoblot. Bands were quantified by integrated density. Each point represents neutrophils isolated from a single mouse. (A-B) Two-way ANOVA with Tukey multiple comparisons test or ( C ) paired t test (** p ≤ 0.01, ns = not significant). Download figure Open in new tab Figure 2: Chronic TLR7/9 signaling suppresses LDHB and impairs lactate-driven suicidal NETosis in lupus-prone neutrophils. ( A - B ) WT or MRL/ lpr neutrophils were treated with differing TLR agonists in the presence or absence of lactate (1 mM) and ( A ) mitochondrial ROS or ( B ) suicidal NETosis were quantified by flow cytometry. ( C - D ) Neutrophils were stimulated with TLR agonist (50 ng/mL) and IFNγ (50 ng/mL) and cultured for 16 hours. Neutrophils were cultured with S. aureus (SA) for 3 hours and ( C ) total LDHB protein relative to an isotype control antibody or ( D ) suicidal NETosis were quantified by flow cytometry. Each point represents neutrophils isolated from a single mouse. Two-way ANOVA with Tukey multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, ns = not significant). Previous work in LCMV-infected dendritic cells demonstrated that chronic TLR7 activation can suppress LDHB expression 54 . Given that nuclear antigens accumulate in SLE and activate endosomal TLRs 55 , 56 , including TLR7, we hypothesized that chronic TLR7 stimulation may similarly repress LDHB in neutrophils, impairing their ability to undergo lactate-driven suicidal NETosis. To test this, WT and MRL/ lpr neutrophils were cultured for 16 hours with IFNγ and TLR agonists (50 ng/mL each), then either mock-treated or stimulated with S. aureus . LDHB protein levels, mitochondrial ROS, and suicidal NETosis were subsequently quantified by flow cytometry. In WT neutrophils, overnight stimulation alone did not alter LDHB expression, but pre- treatment with TLR7 or TLR9 agonists followed by S. aureus challenge led to significant suppression of LDHB protein ( Fig. 2C , S1D) and a corresponding reduction in suicidal NETosis ( Fig. 2D , S1E). Conversely, in MRL/ lpr neutrophils, overnight culture with TLR2 or TLR4 agonists restored LDHB protein levels and partially rescued their capacity to undergo S. aureus -induced suicidal NETosis ( Fig. 2C–D ). These results demonstrate that chronic TLR7 and TLR9 signaling suppresses LDHB expression in neutrophils, impairing their ability to detect bacterial lactate and undergo mitochondrial ROS–dependent suicidal NETosis. HCQ restores suicidal NETosis but MRL/lpr neutrophils have impaired antibacterial activity HCQ, commonly prescribed as Plaquenil, is an acidotropic molecule that binds double- and single-stranded nucleotides and sterically hinders their binding to TLR7/9 57 . Clinically, HCQ is approved for the treatment of SLE and reduces disease flares by dampening type I interferon responses. We previously demonstrated that apoptotic debris triggers aberrant suicidal NETosis in SLE neutrophils 34 . Treating MRL/lpr neutrophils with HCQ prevented this spontaneous NET release in response to apoptotic stimuli ( Fig. 3A ). Download figure Open in new tab Figure 3: HCQ restores mitochondrial ROS and suicidal NETosis but fails to rescue bactericidal activity in MRL/ lpr neutrophils. ( A ) WT or MRL/ lpr neutrophils were treated with HCQ (30 µM) and subsequently stimulated with apoptotic debris. After 3 hours, suicidal NETosis was quantified by flow cytometry. ( B - F ) WT or MRL/ lpr mice were mock treated or treated with HCQ (40 mg/kg) daily for 2 days. Neutrophils were isolated from the bone marrow, cultured with S. aureus (SA) for 3 hours, and ( B ) total LDHB protein relative to an isotype control, ( C ) mitochondrial ROS, neutrophils undergoing ( D ) suicidal NETosis or ( E ) vital NET release were quantified by flow cytometry. ( F ) Neutrophils were cultured with S. aureus for 4 hours, and bacterial killing relative to S. aureus grown in the absence of neutrophils was quantified by dilution spot platting. Each point represents neutrophils isolated from a single mouse. Two-way ANOVA with Tukey multiple comparisons test (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, ns = not significant). To determine whether HCQ also restores the bacterially induced suicidal NETosis in response to S. aureus , WT and MRL/ lpr mice were treated with HCQ every 24 hours for two days. Neutrophils were then isolated and stimulated ex vivo with S. aureus . HCQ treatment in MRL/ lpr mice restored LDHB expression to levels comparable to WT ( Fig. 3B , S2A), increased mitochondrial ROS generation in response to S. aureus ( Fig. 3C , S2B), and re-established the capacity to undergo suicidal NETosis ( Fig. 3D , S2C-D). Despite this restoration of mitochondrial programming, a large subset of MRL/ lpr neutrophils continued to undergo constitutive vital NET release ( Fig. 3E , S2E), a response previously shown to be less effective at bacterial killing 38 . Consistent with this, MRL/ lpr neutrophils from HCQ-treated mice remained deficient in controlling S. aureus infection ex vivo , exhibiting impaired bacterial clearance relative to WT controls ( Fig. 3F ). These findings demonstrate that HCQ treatment can partially rescue suicidal NETosis by restoring LDHB expression and mitochondrial ROS production. However, MRL/ lpr neutrophils still exhibit sustained vital NET release and remain functionally compromised in their antibacterial response. These data suggest that restoring mitochondrial signaling is necessary but not sufficient for effective bacterial clearance in SLE, potentially due to a persistent bias toward vital NET formation. Vital NET release is ineffective at killing S. aureus and interferes with the suicidal NETosis Although HCQ treatment restores mitochondrial ROS and suicidal NETosis in MRL/ lpr neutrophils, the continued presence of constitutive vital NET release may compromise antibacterial function. We hypothesized that vital NET release is intrinsically less bactericidal than suicidal NETosis and may actively suppress the latter, either by depleting cellular resources or enforcing a distinct regulatory program. To experimentally model how one NET program may interfere with another, we established an in vitro system to sequentially activate vital and suicidal NET pathways. Neutrophils were pretreated with A23187, a calcium ionophore that triggers vital NET release 58 , followed by stimulation with phorbol myristate acetate (PMA) or S. aureus , both of which induce suicidal NETosis. A23187 pretreatment led to robust vital NET release ( Fig. 4A-B ) but significantly reduced the fraction of neutrophils undergoing subsequent suicidal NETosis in response to PMA or S. aureus ( Fig. 4C-D ). Conversely, pretreatment with PMA induced suicidal NETosis ( Fig. 4C - D) and suppressed subsequent vital NET release in response to A23187 and S. aureus ( Fig. 4A - B). These findings suggest that vital and suicidal NET programs are mutually antagonistic, consistent with their distinct upstream signaling pathways 58 . Download figure Open in new tab Figure 4: Vital and suicidal NET programs are functionally antagonistic and differ in antibacterial potency and composition. ( A - D ) WT Neutrophils were pre-treated (PT) with PMA (P; 5 µM) or A23187 (A; 50 nM) and subsequently stimulated with PMA, A23187, or S. aureus (SA). ( A-B ) Vital NET release after 30 minutes or ( C-D ) suicidal NETosis after 3 hours were quantified by flow cytometry. ( E - O ) WT and MRL/ lpr neutrophils were treated with PMA or A23187 for 16 hours and the resulting NETs subsequently ( E, O ) cultured with WT or Δ nuc S. aureus for 4 hours. Bacterial killing was quantified relative to S. aureus cultured in the absence of NETs by dilution spot plating. ( F - N ) Alternatively, NETs were stained to quantify ( F ) DNA, ( G, K ) MPO, ( H, L ) NE, ( M ) S100A9, or ( I, N ) H3Cit using a fluorescent plate reader or ( J ) confocal microscopy. Each point represents ( A - D ) neutrophils isolated from a single mouse or ( E - I, K-O ) NETs from neutrophils isolated from a single mouse. ( A - E, K-O ) One-way ANOVA with Tukey multiple comparisons test or ( F - I ) paired t test (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, ns = not significant). To assess whether these NET programs differ in antibacterial potency, neutrophils were stimulated with A23187 or PMA and cultured for 16 hours to allow NET formation. A23187- induced NETs exhibited significantly reduced capacity to kill S. aureus compared to PMA-induced suicidal NETs ( Fig. 4E ). This difference in bactericidal activity was not due to preferential degradation of suicidal NETs by staphylococcal nucleases, as a nuclease-deficient staphylococcal strain (Δ nuc ) remained equally resistant to A23187-induced NETs. Despite their impaired antibacterial function, A23187 stimulation led to more abundant NET deposition than PMA ( Fig. 4F ). However, these vital NETs contained less antimicrobial proteins such as myeloperoxidase (MPO) and elastase (NE), as well as reduced citrullinated histones (H3Cit; Fig. 4G-J ). Together, these results demonstrate that vital NETs are both less bactericidal and capable of antagonizing suicidal NETosis. To further dissect how NET subtype differences contribute to antibacterial efficacy, we compared NET composition and function between WT and MRL/ lpr neutrophils following stimulation with PMA or A23187. Both genotypes released similar amounts of NETs (Fig. S3A), but their composition diverged. Suicidal NETs from MRL/ lpr neutrophils contained lower levels of MPO and NE but elevated calprotectin (S100A9) compared to WT ( Fig. 4K–M ), while vital NETs exhibited modest increases in MPO and calprotectin with similar NE levels. Citrullinated histone content was comparable in vital and suicidal NETs between genotypes ( Fig. 4N ). Suicidal NETs from MRL/ lpr neutrophils were less bactericidal than WT ( Fig. 4O ), consistent with reduced MPO and NE content (Fig. K-L). However, vital NETs from MRL/ lpr neutrophils remained equally ineffective ( Fig. 4O ) despite higher MPO and calprotectin levels ( Fig. 4K, M ). These findings suggest that lupus neutrophils generate less effective suicidal NETs and rely disproportionately on vital NET release, an imbalance that may contribute to impaired bacterial clearance despite excessive NET formation. Staphylococcal pore forming toxins cause calcium influx and vital NET release While the molecular regulation of suicidal NETosis is well characterized, the signaling pathways that drive vital NET release remain poorly defined. Prior work has shown that the pore- forming toxin Panton-Valentine leukocidin (PVL), secreted by S. aureus , can trigger vital NET release 3 . To expand on this, we cultured neutrophils with S. aureus mutants lacking either PVL (Δ pvl ) or α-hemolysin (Δ hla ), another pore-forming toxin. Both mutants induced significantly less vital NET release compared to WT S. aureus ( Fig. 5A ), confirming that these toxins contribute to vital NET release in WT neutrophils. In contrast, MRL/ lpr neutrophils released vital NETs independent of these toxins, consistent with their dysregulated NET program. Download figure Open in new tab Figure 5: Staphylococcal Hla promotes vital NET release by inducing calcium influx in neutrophils. ( A-C ) WT or MRL/ lpr neutrophils were cultured with WT, Δ hla , Δ pvl, or Δhla + hla S. aureus in the presence or absence of Hla protein and vital NET release was quantified after 30 minutes by flow cytometry. ( D ) WT neutrophils were loaded with DiBAC 4 (3) and stimulated with Δ hla and/or Hla protein. The median fluorescence intensity (MFI) was quantified by flow cytometry and normalized to unstimulated neutrophils. ( E ) WT neutrophils were loaded with Fluo-4 and Hoechst 33342 and stimulated with WT or Δ hla S. aureus in the presence or absence of EDTA (0.5 mM) or Hla protein (1 µM). Fluo-4 and Hoechst 33342 fluorescence was quantified temporally using a fluorescence plate reader and normalized to unstimulated neutrophils. ( F ) WT neutrophils were cultured with WT or Δ hla S. aureus in the presence of EDTA or Hla protein. Vital NET release was quantified by flow cytometry. Each point represents ( A - D, F ) neutrophils isolated from a single mouse or ( E ) the mean normalized (Fluo-4/Hoechst 33342) relative fluorescence intensity (RFI) from neutrophils isolated from 5 mouse. ( A ) Two- or ( B - D, F ) one-way ANOVA with Tukey multiple comparisons test. ( E ) Error bars = standard error (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, ns = not significant). Although PVL promotes vital NET release, we excluded it from further experiments due to its capacity to trigger mitochondrial ROS and suicidal NETosis 33 , which could confound downstream analysis. The Δ hla strain did not affect NETosis (Fig. S3B), and thus became the focus of subsequent studies. Expressing Hla in trans ( Fig. 5B ) or adding exogenous Hla protein ( Fig. 5C , S3C) restored vital NET release by WT neutrophils exposed to the Δ hla strain. However, Hla protein alone was insufficient to trigger NET release, indicating that it acts in synergy with other bacterial factors. Together, these data demonstrate that S. aureus pore-forming toxins, including Hla, are key inducers of vital NET release during infection. Neutrophils are relatively resistant to Hla-mediated lysis, suggesting that Hla may have immunomodulatory functions beyond cytotoxicity. Differing studies have produced contrasting results where Hla permits calcium influx 59 or causes depolarization of the cell membrane and prevented calcium influx 60 leading to enhanced neutrophil inflammatory responses 59 , 61 – 63 but impaired chemotactic migration 60 , 64 . To test whether Hla alters membrane potential, we loaded neutrophils with the voltage-sensitive dye DiBAC4(3) and stimulated them with the Δ hla strain, Hla protein, or both. Each treatment increased DiBAC4(3) fluorescence, indicating membrane depolarization, but the combination of Δ hla and Hla protein caused a further increase beyond either treatment alone ( Fig. 5D , S3D). This suggests that Hla induces depolarization, likely via sodium influx 60 , and that co-stimulation with S. aureus further amplifies depolarization through a distinct ion flux. Because prior work also implicated Hla in calcium signaling 60 , we tested whether S. aureus triggers calcium influx. Neutrophils loaded with the calcium-sensitive dye Fluo-4 showed a rapid and robust increase in intracellular calcium in response to WT S. aureus , which was markedly reduced in cells treated with the Δ hla strain or calcium chelator EDTA ( Fig. 5E ). Hla protein alone did not elicit calcium influx, but co-treatment with the Δ hla strain restored calcium responses to WT levels, indicating that Hla promotes calcium entry only in the context of bacterial stimulation. Furthermore, vital NET release was diminished when WT neutrophils were stimulated with the Δ hla mutant or treated with EDTA ( Fig. 5F ), underscoring the requirement for both calcium influx and pore-forming toxins. These findings support a model in which Hla-dependent pore formation enables calcium entry into neutrophils, triggering vital NETosis during S. aureus infection. IFNα sustains vital NET release in MRL/lpr neutrophils responding to S. aureus IFNα has been shown to induce vital NET release in response to pathogens such as Mycobacterium tuberculosis 36 . Given that vital NETs are released within minutes of S. aureus stimulation 3 , we hypothesized that IFNα-driven autocrine signaling in this context relies on the rapid secretion of preformed protein rather than de novo transcription or translation. Specifically, we posited that calcium influx triggers degranulation and release of IFNα stores 65 – 67 . To test this, neutrophils were stimulated with WT or Δ hla S. aureus , and surface expression of CD63 and CD35 was quantified by flow cytometry as markers of primary and secretory degranulation, respectively. Primary degranulation in response to S. aureus was dependent on the presence of Hla and calcium as the Δ hla strain did not trigger and EDTA prevented release of primary granules ( Fig. 6A , S3E). In contrast, MRL/ lpr neutrophils released primary granules in response to S. aureus independent of Hla or calcium availability. Secretory degranulation in response to S. aureus was dependent solely on the presence of calcium as the Δ hla strain triggered release of secretory granules ( Fig. 6B ). These findings indicate that S. aureus -induced degranulation is differentially regulated: primary granule release requires both Hla and calcium, while secretory granule release depends only on calcium. Download figure Open in new tab Figure 6: IFNα secretion coincides with calcium-dependent degranulation and is dysregulated in lupus-prone neutrophils. ( A - D ) WT or MRL/ lpr neutrophils were cultured with WT or Δ hla S. aureus in the presence or absence of EDTA or Hla protein. After 30 minutes, neutrophils were stained for surface expression of ( A ) CD63 (primary granules) or ( B ) CD35 (secretory granules) and quantified by flow cytometry or ( C ) supernatants isolated to quantify IFNα by ELISA. ( D - E ) WT or MRL/ lpr neutrophils were ( D ) treated with Cl-amidine to broadly inhibit NET release, IFNα, and/or an α-IFNAR1 antibody and cultured with S. aureus or ( E ) treated with TLR agonists in the presence or absence of IFNα. After 3 hours, vital NET release was quantified by flow cytometry. Each point represents neutrophils isolated from a single mouse. Two-way ANOVA with Tukey multiple comparisons test (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant). To determine whether IFNα is released during degranulation, we quantified IFNα secretion by ELISA. WT neutrophils released IFNα in response to WT S. aureus , but not to the Δ hla strain ( Fig. 6C ). This defect was rescued by adding Hla protein, confirming that Hla is required for IFNα release. However, calcium chelation with EDTA abolished IFNα secretion, indicating that release is calcium-dependent. This pattern mirrored primary granule degranulation and suggests that IFNα is either stored in primary granules or released concurrently with them. In contrast, MRL/ lpr neutrophils secreted IFNα regardless of Hla or calcium ( Fig. 6C ), consistent with their constitutive, dysregulated NET phenotype. Together, these results support a model in which staphylococcal pore-forming toxins initiate IFNα release that drives vital NET release, a pathway that is uncoupled or rendered constitutively active in lupus-prone neutrophils. We next tested whether IFNα sustains chronic vital NET release. MRL/ lpr neutrophils released more vital NETs than WT neutrophils after 3 hours of S. aureus stimulation ( Fig. 6D , S3F), consistent with prior studies 38 . Recombinant IFNα enhanced NET release in both WT and MRL/ lpr neutrophils, while IFNAR1 blockade or PAD4 inhibition suppressed it. However, IFNα alone was insufficient as TLR co-stimulation was required. In TLR agonist assays, IFNα enhanced NETosis only when paired with a TLR ligand, except in MRL/ lpr neutrophils responding to TLR2/1, which released NETs even without IFNα ( Fig. 6E ). These results suggest that TLR2/1 signaling bypasses IFNα dependence in lupus-prone neutrophils and that IFNAR–PAD4 signaling integrates with bacterial sensing to sustain vital NETosis. Overall, our findings support a model in which Hla triggers calcium-dependent IFNα release, which then sustains NET release via IFNAR and PAD4, a program that becomes dysregulated in lupus. IFNα plays a critical role in driving SLE pathology and similarly, MRL/ lpr mice have increased serum IFNα (Fig. S4A). Thus, high circulating IFNα may exacerbate vital NET release during infection, impairing the transition to mitochondrial ROS-driven suicidal NETosis. To test this, WT and MRL/ lpr mice were systemically infected with S. aureus by retro-orbital inoculation and treated with either vehicle, HCQ, an anti-IFNAR1 antibody, or both. MRL/ lpr mice had elevated autoantibody titers and mild glomerulonephritis (proteinuria score ≤ 2) at the time of infection (Fig. S4B-C). Both WT and MRL/ lpr mice treated with anti-IFNAR1 were highly susceptible to S. aureus bacteremia. Dual treatment with HCQ and anti-IFNAR1 in MRL/ lpr mice did not significantly improve survival ( Fig. 7A ) despite similar weight loss across treatment groups (Fig. S4D). However, bacterial burdens in the heart and liver were significantly decreased with a strong trend observed in the kidney in dual-treated MRL/ lpr mice relative to vehicle controls ( Fig. 7B ). The decrease in bacterial burdens coincided with restoration of LDHB expression ( Fig. 7C , S4E), suicidal NETosis ( Fig. 7D , S4F), and normalization of vital NET release ( Fig. 7E , S4G). These results demonstrate that combined HCQ and IFNAR1 blockade restores mitochondrial function and rebalances NET responses in lupus-prone mice, improving bacterial clearance. However, the modest survival benefit despite improved bacterial control suggests that neutrophil dysfunction is only one facet of infection susceptibility in SLE. These findings underscore the multifactorial nature of immune dysregulation in lupus and highlight the need to address broader inflammatory and tissue-damaging pathways in this setting. Download figure Open in new tab Figure 7: Combined HCQ and IFNAR1 blockade restores NET subtype balance and antibacterial defense in lupus-prone mice. WT or MRL/ lpr mice were retro-orbitally infected with S. aureus and treated with vehicle, HCQ (40 mg/kg/ every other day), and/or anti-IFNAR1 antibody (10 mg/kg/every other day). ( A ) Mouse survival was monitored daily post-infection. At 6 days post-infection, ( B ) bacterial burdens in the heart, liver, and kidney were quantified by dilution spot plating and neutrophils from the tissues analyzed for ( D ) LDHB protein expression relative to isotype control, ( E ) mitochondrial ROS, ( F ) suicidal NETosis, and ( G ) vital NET release by flow cytometry. ( A ) Data represents the mean survival of mice and ( B - G ) each point represents a single mouse. ( A ) Log-rank (Mantel–Cox) test and ( B - G ) two-way ANOVA with Tukey multiple comparisons test (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant). HCQ and Anifrolumab therapies restore regulation of NET release by SLE neutrophils MRL/ lpr mice are genetically identical and housed in controlled conditions, whereas SLE in patients arises from diverse genetic and environmental influences. To determine whether the mechanisms identified in lupus-prone mice extend to human disease, we analyzed neutrophils from individuals with SLE (Tables S1-S2). Neutrophils were isolated from healthy controls (HC) and SLE patients, and LDHB protein expression was quantified by flow cytometry. SLE neutrophils from patients receiving higher doses of HCQ, normalized to body weight, expressed significantly more LDHB compared to those on lower doses, though levels remained reduced relative to HC neutrophils ( Fig. 8A–B ). Ex vivo treatment of SLE neutrophils with S. aureus and HCQ increased LDHB expression to levels comparable to HC controls. Given this rescue of LDHB, we next assessed mitochondrial ROS production ( Fig. 8C–D ) and suicidal NETosis ( Fig. 8E–F ) in response to S. aureus . We analyzed responses both in freshly isolated neutrophils and by retrospectively correlating HCQ dosing with prior data 34 , 38 . SLE neutrophils from patients on higher doses of HCQ produced more mitochondrial ROS and underwent greater suicidal NETosis following S. aureus challenge ( Fig. 8C, E ). In addition, ex vivo HCQ treatment restored both responses to levels seen in HC neutrophils ( Fig. 8D, F ). These findings indicate that HCQ dose- dependently restores LDHB expression and mitochondrial programming, thereby rescuing the capacity for suicidal NETosis in SLE neutrophils. Download figure Open in new tab Figure 8: HCQ and anifrolumab therapies restore NET subtype regulation in SLE neutrophils. Neutrophils were isolated from HC or SLE patients. ( A - B ) LDHB protein expression relative to isotype control in unstimulated neutrophils, or ( C - D ) mitochondrial ROS, ( E - F ) suicidal NETosis, ( G - H ) vital NET release in response to S. aureus were quantified by flow cytometry. ( A, C, E ) LDHB expression, mitochondrial ROS, and suicidal NETosis was graphed relative to current dosage of HCQ. ( G ) Vital NET release were quantified in patients not receiving or receiving anifrolumab (anif.) treatment. (B, D, F, H) Neutrophils were treated with IFNα, HCQ, and/or anifrolumab and stimulated with S. aureus for 3 hours. Each point represents neutrophils isolated from a single donor. ( A , C , E ) Data were quantified by linear regression or ( B, D, F-H ) one-way ANOVA with Tukey multiple comparisons test (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns = not significant). ( C, E, G ) Includes data from this study and prior studies 34 , 38 . We next assessed chronic vital NET release in response to S. aureus . Neutrophils from SLE patients receiving anifrolumab exhibited significantly less vital NET release compared to untreated patients ( Fig. 8G ). Furthermore, anifrolumab suppressed vital NET formation to levels observed in HC neutrophils, while exogenous IFNα augmented vital NET release in HC neutrophils to levels resembling SLE ( Fig. 8H ). Together, these findings demonstrate that the aberrant NET program observed in lupus-prone mice is recapitulated in human SLE neutrophils and can be pharmacologically reversed. HCQ restores mitochondrial function and suicidal NETosis, while anifrolumab suppresses IFNα-driven vital NET release, providing mechanistic insight into how standard-of-care therapies modulate innate immune dysfunction in SLE. Discussion Neutrophils are essential for early antibacterial defense, yet in SLE, their responses become paradoxically maladaptive. Excessive NET formation fuels autoimmunity 27 – 29 , while susceptibility to infections like S. aureus remains high 46 – 49 . This contradiction suggests that not all NETs are equal in function. Here, we reveal that chronic innate immune activation in lupus reshapes NET output from bactericidal suicidal NETosis to a constitutive, ineffective vital NET program, undermining host defense despite increased NET burden. We identify a TLR7/9-IFNα-LDHB immunometabolic axis that governs neutrophil NET programming. Similar to LCMV-infection in dendritic cells 54 , chronic TLR7/9 stimulation during SLE represses LDHB, a mitochondrial enzyme required for lactate sensing and ROS production during bacterial infection 34 . This repression severs a key metabolic checkpoint, blocking mitochondrial ROS and suicidal NETosis in response to S. aureus . Instead, lupus-prone neutrophils default to vital NET release, a program we show is less bactericidal and actively antagonizes suicidal NETosis, likely through pathway competition and granule depletion. We further elucidate the upstream regulation of vital NET release. Staphylococcal Hla facilitates calcium influx and degranulation, initiating rapid IFNα secretion and vital NET formation. In healthy neutrophils, this occurs via a tightly regulated process that depends on intact calcium signaling. This is consistent with earlier work demonstrating that S. aureus triggers rapid, vesicle- mediated NET release via non-lytic, oxidant-independent pathways, particularly in response to PVL and related pore-forming toxins 3 . More recently, type I interferon was shown to enable neutrophils to extrude NETs while maintaining membrane integrity in TB granulomas 36 . These findings align with our observation that IFNα signaling amplifies vital NET release and suggest that this pathway, while beneficial in some contexts, may become pathologically unrestrained in SLE. In lupus-prone neutrophils, IFNα release becomes decoupled from calcium dependence, enabling constitutive autocrine IFNAR signaling that sustains vital NET formation. Our findings reconcile previously conflicting reports on Hla’s effects on calcium flux and neutrophil activation 59 – 64 , and position vital NETosis as a context-dependent, IFNα-amplified program that contributes to defective host defense in lupus. This NET subtype imbalance has functional consequences. Vital NETs lack the antimicrobial protein content and killing capacity of suicidal NETs, yet are produced in greater abundance. In lupus-prone neutrophils, this imbalance not only fails to control S. aureus but also suppresses the more effective suicidal program, compounding infection risk. Both vital and suicidal NETs from MRL/lpr neutrophils contained elevated levels of S100A9, consistent with the increased calprotectin expression we previously reported in lupus neutrophils 38 . Although calprotectin contributes to antibacterial defense 68 , 69 , our findings demonstrate that its enrichment alone is insufficient to compensate for the loss of effective suicidal NETosis. These results align with recent evidence that S. aureus PVL triggers vital NET formation, yielding NETs with reduced NE, cathelicidin, and proteinase 3 content and poor bactericidal activity 70 . Instead, the skew toward vital NET release exacerbates functional defects, impairing bacterial clearance despite excessive NET deposition. These findings resolve a longstanding paradox in lupus pathogenesis: NET abundance is not protective when the dominant subtype lacks bactericidal potency. Importantly, this dysregulated NET program is therapeutically reversible. In lupus-prone mice, HCQ restores LDHB expression, mitochondrial ROS, and suicidal NETosis by blocking endosomal TLR7/9 signaling. IFNAR blockade with anti-IFNAR1 antibody disrupts IFNα-driven vital NET release. Combined therapy rebalances NET subtypes and reduces bacterial burden in vivo. In human SLE neutrophils, defects in LDHB and NET programming mirror those in mice, and are corrected by HCQ or anifrolumab, providing mechanistic rationale for these therapies and their benefits to innate immunity. However, rebalancing NET responses alone was insufficient to improve survival in septic lupus-prone mice, highlighting the multifactorial nature of infection vulnerability in SLE. Factors such as impaired macrophage function 25 , 26 , 71 – 74 , vascular pathology 14 – 20 , and complement deficiencies 75 likely contribute to poor outcomes. Moreover, it remains to be seen whether similar NET imbalances impair responses to other pathogens, including viruses and fungi, particularly given the critical role of IFN signaling in antiviral defense. Our findings underscore several broader implications. First, NET subtype identity is functionally decisive, not merely morphological. Suicidal NETosis is linked to robust antimicrobial content and cell death, whereas vital NETs are non-lytic, less antimicrobial, and suppress more effective NET programs. Second, LDHB emerges as a central metabolic node linking innate immune signaling to mitochondrial fitness and effector function, one that may be dysregulated across multiple cell types and diseases marked by chronic inflammation 76 – 79 . Finally, NET subtype composition may represent a tractable biomarker of neutrophil health and treatment response in SLE and other inflammatory diseases. In summary, this study identifies a TLR7/9-IFNα-LDHB axis that rewires neutrophil NET programming in lupus. By defining how chronic inflammation impairs antibacterial immunity through metabolic and signaling reprogramming, we reveal an actionable mechanism that reconciles key paradoxes in SLE pathogenesis and lays the groundwork for targeting innate dysfunction in autoimmune disease. Methods Reagents Antibodies specific for Ly6G (127643), CD15 (323050), CD16 (302016), CD63 (143903), CD21/35 (123409), and PE isotype control (400508) were from Biolegend. CD11b (60-0112- U100) was from Tonbo and LDHA (PA523036) and LDHB (MA541126) were from Invitrogen. Streptavidin Alexa Fluor 488 (405235), rabbit Alexa Fluor 488 (405235), and rabbit Alexa Fluor 647 were purchased from Biolegend. MPO (AB90810), H3Cit (AB5103), and Neutrophil Elastase (AB68672) were from Abcam and S100A9 (73425) was from Cell Signaling. Murine Fc Shield (70- 0161-M001) was purchased from Tonbo and Human TruStain FcX (422302) was from Biolegend. Paraformaldehyde (15710) was from Electron Microscopy Sciences. MitoSOX red (M36008), MitoTracker deep red (M22426), SYTOX blue (S34857), DiBAC4(3) (B438), Cell Mask deep red (C10046), and prolong gold (P36930) were purchased from Invitrogen. Hoechst 33342 (62249) and Fluo-4 (F14201) were from Thermo Scientific and Ghost Dye Violet 540 (13-0879-T100) was from Tonbo. Histopaque 1077 (10771-6X100ML), Histopaque 1119 (11191-6X100ML), and Poly- L Lysine (P4707) were purchased from Sigma-Aldrich. DMEM (11-965-118) and FBS (A52567- 01, Lot 2635802RP) were from Gibco, DPBS (16750-102) was from Cytiva, and 10X RBC lysis buffer (420302) was from Biolegend. α-dsDNA (AB27156) and IgG AP (AB98724) were purchased from Abcam and salmon sperm DNA solution (15632011) was from Invitrogen. Laemmli loading buffer (1610747) was from BioRad and the chemiluminescent substrate kit (34580) was from Thermo Scientific. The antibodies SOD2 (D3X8F) and goat anti-rabbit IgG HRP (W401B) were from Cell Signaling and Promega, respectively. The mitochondrial isolation kit (89874) was purchased from Thermo Scientific and the mouse IFNα ProQuantum Immunoassay kit (A46736) was from Invitrogen. The Turbo DNAse kit (AM1907), RNA HS kit (Q32852), and SuperScript III first strand synthesis kit (18080051) were purchased from Invitrogen. The RNeasy mini kit (74104) and Proteinase K (19131) were from Qiagen. Mutanolysin (M9901-1KU) was from Sigma, lysozyme (90082) was from Thermo Fisher, and EDTA (BP2482100) was from Fisher. TaqMan Gene Expression Master Mix (4369514) was purchased from Applied Biosystems. NaLactate (71718), PMA (P8139), A23187 (AC328080050), Cl-Amidine (506282), Hla protein (H9395), and LPS (L4391-10) were purchased from Sigma-Aldrich. Pam2CSK4 (4637), Pam3CSK4 (4633), Poly I:C (4287), and Imiquimod (3700) were from Tocris. Mouse IFNγ (315- 05), and human IFNα (300-02AA) were from PeproTech. CpG ODN (TLRL1826) was purchased from Invivogen. Mouse α-IFNAR (127324) and Mouse IFNα (752806) were from Biolegend and human α-IFNAR (A2460) was from Selleck. Bacteria All S. aureus experiments used the bacterial strain USA300 (LAC). The Δ nuc mutant 1 was from the Horswill lab. The ΔPVL strain was from the Nebraska Transposon Mutant Library 80 and the Δ hla mutant 81 was from Megan Kiedrowski. Bacteria were maintained as a -80°C glycerol stock, and S. aureus was streaked onto tryptic soy agar (TSA; 2% agar) plates to grow overnight at 37°C. Single colonies were transferred to tryptic soy broth (TSB) and liquid cultures were grown overnight at 37°C with 250 rpm of shaking. For all in vitro experiments, overnight cultures were diluted 1:50 into non–heat-inactivated FBS before coculture with neutrophils. Mice C57BL/6J and MRL/MpJ- Fas lpr /J mice were purchased from the Jackson Laboratory (JAX mice stock no. 000664 and no. 000485). A C57BL/6J breeding colony was subsequently maintained in an accredited animal facility. Mice were housed two to five mice per cage with an independently ventilated air supply and food and water were provided ab libitum. Cages were changed on a weekly basis. For hydroxychloroquine (HCQ) treatments, mice were injected intraperitoneally at a concentration of 40 mg/kg every 24 hours for 2 days prior to neutrophil isolation. Mock treatment was the diluent (DPBS). All experiments were conducted in accordance with protocols approved by the University of Tennessee Institutional Animal Care and Use Committee. Human neutrophil isolation Neutrophils were isolated from the peripheral blood of donors using density centrifugation where neutrophils were isolated at the interface between layers of Histopaque 1119 and Histopaque 1077. Serum was pulled off the top of the blood prior to density centrifugation each experiment for opsonization of bacteria. Blood was diluted with DPBS then layered on top of 2-3 Histopaque stacks. Isolated neutrophils were washed with DMEM and then incubated on ice for 45 minutes in DMEM with 10% FBS (D10 media) before lysing red blood cells with 1-2mL 1X RBC lysis buffer. The isolated neutrophils rested 1 hr at 37°C, 5% CO 2 before experiments. The isolated cells were 90-95% neutrophils (CD15 + CD16 + ), as verified by flow cytometry. Murine neutrophil isolation Single-cell suspensions of bone marrow were extracted from the tibias and femurs of female mice aged 6-10 weeks and layered on top of a Histopaque stack. Following density centrifugation, the neutrophils were isolated at the interface of Histopaque 1077 and Histopaque 1119. The cells were washed with DMEM and resuspended in D10 media. The neutrophils were rested on ice for 1 hr, plated, and allowed to rest for 1 hr at 37°C, 5% CO 2 before experiments. Alternatively, neutrophils were cultured with IFNγ and TLR agonists (50 ng/mL) for 16 hours at 37°C, 5% CO 2 before conducting experiments. The isolated cells were 85-95% neutrophils (CD11b + Ly6G + ), as verified by flow cytometry. Apoptotic Debris Following euthanasia, the thymus was removed from a mouse less than 15 weeks of age, grinded through a 70 µm cell strainer and rinsed with DPBS. Cells were irradiated (6 gray), placed in a 6 cm petri dish, and incubated at 37°C, 5% CO 2 overnight. The next day the sample was transferred to a 15 mL conical tube and pelleted at 350 x g for 5 min. Supernatant containing apoptotic debris was transferred to a fresh tube and added to serum to stimulate neutrophils. Murine bacteremia models S. aureus was streaked from frozen stocks on TSA. Overnight cultures of S. aureus were grown in TSB and then subcultured 1:100 in 5 mL of TSB. S. aureus was grown for 3 hours, washed, and resuspended in ice-cold DPBS. Bacteria was resuspended at 2×10 8 CFU/mL for C57BL/6 or 4×10 8 CFU/mL for MRL/ lpr to account for the differences in size between the two mice. All infections used 10- to 12-week-old female mice, which were anesthetized using inhalation of isoflurane followed by inoculation of the retro-orbital sinus with 100 µL of bacterial slurry or mock treated with 100 µL DPBS. A lubricant eye ointment was applied after each injection and mice were monitored until they regained consciousness. Mice were monitored daily before humane euthanasia by inhalation of CO 2 . For anti-IFNAR (anifrolumab) and hydroxychloroquine (HCQ) treatments, mice were injected intraperitoneally every other day beginning the day after infection. Anti-IFNAR was administered at a concentration of 10 mg/kg and HCQ at 40 mg/kg. Mock treatments were the respective diluent. One day prior to infection, murine levels of proteinuria and serum autoantibody were quantified. Urine protein was assessed according to Uristix 4 (Siemens) instruction. Blood was collected by tail nick and serum levels of IgG reactive to dsDNA was quantified by ELISA. Organ Harvest Following euthanasia, the heart, liver, and kidney were removed, weighed and placed into tubes containing DPBS on ice. Blood was collected from cardiac sticks for IFNα ELISA. Single cell suspensions were created by grinding organs through 70 µm cell strainers and rinsing in DPBS. Aliquots of 200 µL of the single cell suspension were reserved for serial dilution spot plating before centrifugation to determine bacterial load. Cells were pelleted and the pellets resuspended with 1X RBC lysis buffer per manufacturer’s instructions. Cells were strained through a 70 µm cell strainer, pelleted by centrifugation, washed in DPBS, and resuspended in FACs media (DPBS with 2% heat inactivated FBS and 0.02% NaAz) and plated for flow cytometry. Bacterial Burdens from Infections Samples were aliquoted into the top row of a 96 well plate and then serially diluted in DPBS using 10-fold increments down the plate. 5 µL of each dilution was then spotted onto TSA plates and incubated for 12-16 hours in a static 37°C incubator. Plates were removed from the incubator and CFU counted. Flow Cytometry An Attune NXT flow cytometer was used to run all flow cytometry assays. All data was analyzed using FlowJo software. For all flow cytometry data, cells were gated side scatter height (SSC-H) by side scatter area (SSC-A) followed by forward scatter height (FSC-H) by forward scatter area (FSC-A) to remove doublet populations. The singlet population was gated SSC-H by FSC-H to isolate the granulocyte populations. The resulting cell population was then assessed for assay-specific fluorescent markers as described below. Exogenous Treatments Neutrophils were pre-treated with HCQ (30 pM) 30 minutes prior to stimulation and EDTA (0.5mM) 5 minutes prior to stimulation. Neutrophils were stimulated with bacteria at an MOI = 10. Cl-amidine (34 µg/mL), IFNα (200 units/well), α-IFNAR (10 µg/mL), Pam2CSK4 (1 µg/mL), Pam3CSK4 (1 µg/mL), Poly I:C (20 µg/mL), LPS (1 µg/mL), imiquimod (2 µg/mL), CpG ODN (45 nM), sodium lactate (1 mM), and/or Hla protein (1 µg/mL) were added concurrently with bacteria. A23187 (5 µM) and PMA (50 nM) were added to trigger vital NET release or suicidal NETosis. Alternatively, A23187 or PMA were added 30 minutes prior subsequent simulations or bacteria. Mitochondrial ROS Flow Following plating, neutrophils were stained with mitoTracker (500 nM) deep red and mitoSOX red (5 µM) dyes for 20 min, washed, and fresh D10 media added to the neutrophils. Neutrophils were stimulated for 3 hours. Neutrophils were stained with Ghost Dye™ Violet 540 to monitor membrane integrity 20 min prior to fixation. Neutrophils were fixed with room temperature 4% PFA and placed on ice for 20 min. Neutrophils were pelleted and blocked in FACS media (mouse = Fc Shield; human = Human TruStain FcX) on ice for 20 min. Neutrophils were pelleted, and resuspended in FACS media containing fluorescent antibodies (mouse = α-CD11b, α-Ly6G; human = α-CD16, α-CD15) for 20 min on ice. Neutrophils were washed and resuspended in FACS media for analysis. Cells were gated for live cells (Ghost - ) and then neutrophils (CD11b + Ly6G + or CD15 + CD16 + ). mitoSOX and mitoTracker mean fluorescence intensity (MFI) were normalized to untreated or mock WT MFI. NETosis Flow NETosis flow was conducted as previously described 7 . Neutrophils were stimulated for 30 minutes or 3 hours and Ghost Dye™ Violet 540 and SYTOX blue (500 nM) were added to the culture 20 min prior to fixation to monitor membrane integrity and extracellular DNA, respectively. Neutrophils were fixed with room temperature, 4% PFA for 20 min on ice and subsequently blocked in FACS media (mouse = Fc Shield, human = Human TruStain FcX) on ice for 20 min. Neutrophils were pelleted and resuspended in FACS media containing fluorescent antibodies (mouse = α-CD11b, α-Ly6G; human = α-CD16, α-CD15) and biotinylated α- myeloperoxidase and rabbit α-H3Citruline for 20 min on ice. Neutrophils were pelleted and resuspended in FACS media containing fluorescently-labeled streptavidin and α-rabbit antibodies on ice for 20 min. Neutrophils were washed and resuspended in FACS media for analysis. Cells were gated for neutrophils (CD11b + Ly6G + or CD15 + CD16 + ) and cells positive for extracellular dsDNA (SYTOX + ), MPO, and H3Cit were defined as having NET release. Neutrophils releasing NETs that have permeabilized membranes (Ghost + ) were defined as having undergone suicidal NETosis, while Neutrophils releasing NETs that do not have permeabilized membranes (Ghost - ) were defined as having undergone vital NET release. The percentage of neutrophils undergoing NETosis was quantified relative to the total number of neutrophils. LDH Protein Flow To quantify intracellular LDH abundance, neutrophils were stained with Ghost Dye™ Violet 540 20 min prior to fixation, fixed with room temperature 4% PFA for 20 min on ice, blocked in FACS media (mouse = Fc Shield; human = Human TruStain FcX) on ice for 20 min, and stained in FACS media containing fluorescent antibodies (mouse = α-CD11b, α-Ly6G; human = α-CD16, α-CD15) on ice. Neutrophils were then stained with a rabbit α-LDHA or -LDHB antibody or isotype control in Saponin Permeabilization Buffer for 20 min on ice, and stained with a fluorescent α-rabbit antibody in Saponin Permeabilization Buffer for 20 min on ice. Neutrophils were washed and resuspended in FACS media for analysis. LDH MFI was normalized to an isotype control. Degranulation Flow Neutrophils were stimulated for 30 minutes and stained with Ghost Dye™ Violet 540 20 min prior to fixation, fixed with room temperature 4% PFA for 20 min on ice, blocked in FACS media (Fc Shield) on ice for 20 min, and stained with antibodies recognizing appropriate neutrophil surface markers (murine: CD11b, Ly6G; human: CD15, CD16), anti-CD63 (primary), and anti-CD35 (secretory) or appropriate isotype controls in FACS media for 20 min on ice. Cells were washed following staining and resuspended in FACS media for analysis. Cells were gated for live cells (Live/Dead-negative) and then neutrophils (CD11b- and Ly6G-positive). The median fluorescence intensity (MFI) was quantified for surface CD63 and CD35 relative to staining with an isotype control antibody. Membrane Polarization Flow After an hour rest, neutrophils were stained with 250 nM DiBAC4(3) for 8 minutes at 37°C then stimulated for ten minutes and run on the flow cytometer. The median fluorescence intensity (MFI) was quantified for DiBAC4(3) and normalized to unstimulated neutrophils. Confocal Microscopy NET Microscopy Neutrophils were stained with CellMask deep red (5 mg/mL) and incubated at 37°C for 30 min. Cells were washed and 4×10 5 neutrophils were plated in 150 uL of D10 on a poly-L Lysine coated 8 Well Chambered Cover Glass. After 1 hr incubation at 37°C, 5% CO2 cells were stimulated with Baclight Red-stained strains of S. aureus for indicated times. Hoescht 33342 (10 mM) was added during the last 30 min of incubation. Following stimulation the media was aspirated and neutrophils fixed with 4% PFA for 20 min ProLong Gold Antifade reagent was then applied. For HCQ (30pM) treatment, neutrophils were pretreated for 30 min prior to stimulation with S. aureus . NETs were imaged on a ZEISS LSM 900 with Airyscan. 2 confocal microscope. Images were analyzed using ImageJ software. Anti-dsDNA IgG ELISA Vinyl 96-well plates were coated with dsDNA (10µg/mL) and incubated overnight at 4°C. The wells were washed before and after blocking and samples/standards were added before incubating overnight at 4°C. Captured antibodies were detected with anti-mouse IgG-alkaline phosphatase, A standard curve was generated using α-dsDNA and antibody. Absorbance at 405 nm for each well was quantified using a BioTek Cytation plate reader. Samples and standards were read in duplicate and DNA abundance was quantified relative to the standard. IFNα ELISA In-vitro supernatant samples and serum samples were diluted 1:3 and 1:10 respectively in assay dilution buffer. Total IFNα protein was quantified using Mouse IFNα ProQuantum Immunoassay Kit following manufacturer instructions. Plates were ran on a Quantstudio 3 (Applied Biosystems). Mitochondrial Protein Immunoblot Murine neutrophils were pooled from 2 mice and mitochondria were isolated from the cytosol (Thermo Scientific, 89874) per manufacturer instructions. Mitochondrial fractions were lysed using 1X RIPA containing protease inhibitors. Mitochondrial lysates were heated for 5 minutes at 100°C in the presence of Laemmli loading buffer containing β-mercaptoethanol. A volume of 25 µL/well was loaded onto a 15% polyacrylamide gel, followed by electrophoresis. Gels were transferred onto nitrocellulose using a Trans-Blot Turbo and blocked at 4°C with Intercept (TBS) blocking buffer for 4 h before an overnight incubation in either primary LDHB or SOD2 diluted at 1:1,000 in TBST with 1% milk. Secondary antibody incubations were done for 4 hours with 1:10,000 goat anti-rabbit IgG HRP before developing with a Chemiluminescent Substrate kit (Thermo Scientific, 34580) per manufacturer instructions. Blots were then imaged on an iBright 1500 and densitometry quantified by ImageJ software. Fluorescent Plate Reader Assays Calcium Murine neutrophils were isolated and resuspended in clear D10 and stained with Fluo-4 calcium dye (1:2,000) for 40 minutes and Hoechst dye (1:1000) for 20 minutes. The cells were washed and plated (250,000/well) in clear D10 media in a black-wall, clear bottom, 96-well plate that was Poly-L Lysine coated. After an hour rest at 37°C, 5% CO 2 , fluorescence intensity of total DNA (Hoescht 33342) and calcium were read on a Biotek Cytation plate reader. Neutrophils were stimulated with bacteria at an MOI of 10 and Hoechst 33342 and Fluo-4 fluorescence was read every 5 minutes for 1 hour. Characterization of A23187 and PMA induced NETs Murine neutrophils were isolated and plated (500,000/well) on a Poly-L Lysine coated, black wall, clear bottom plate. A23187 (5 uM) and PMA (50 nM) were added to the neutrophils and the plate was cultured for 16 hours at 37°C, 5% CO 2 . Wells were stained with SYTOX blue (500 nM) to quantify total DNA and antibodies specific to MPO, NE, and H3Cit with appropriate fluorescent secondary antibodies to quantify protein abundance. Dilution Spot Plate Assays Neutrophil killing assay Neutrophils were seeded at 2×10 5 cells/well in a 96-well plate and were allowed to rest for 30 min in a 37°C, 5% CO 2 incubator. Neutrophils were challenged with S. aureus opsonized in 1:1 DMEM:non-heat inactivated FBS at a MOI = 0.5. After 4 hours, samples were serially diluted and spot-plated onto TSA. Percent growth was quantified relative to bacteria grown in the absence of neutrophils. NET killing assay Murine neutrophils were isolated and plated (500,000/well) on a Poly-L Lysine coated, black wall, clear bottom plate. A23187 (5 uM) and PMA (50 nM) were added to the neutrophils and the plate was cultured for 16 hours at 37°C, 5% CO 2 . Neutrophils were challenged with S. aureus at a MOI = 0.2. After 4 hours, samples were serially diluted and spot- plated onto TSA. Percent growth was quantified relative to bacteria grown in the absence of neutrophils. Quantitative PCR RNA was extracted from murine neutrophils using the Qiagen RNeasy mini kit following an enzymatic digestion with lysis buffer supplemented with lysozyme (2.88 mg/mL), mutanolysin (2.4 U/µL), proteinase K (3.85 mg/mL), and EDTA (19.2 mM). RNA was further purified by performing a second DNAse treatment with Turbo DNAse kit following the manufacturer’s protocol. RNA was quantified using a qubit RNA HS kit. 318 ng of RNA was then reverse transcribed to cDNA using the SuperScript III First-Strand Synthesis Kit. Quantitative PCR (qPCR) was performed using TaqMan assays to quantify transcript levels of LDHa (Mm01612132_g1 FAM), LDHb (Mm01267402_m1), and IFNα (Mm03030145_gH). Assays were prepared in triplicate with the TaqMan Gene-Expression Master Mix, and the plates were run on the QuantStudio 3 Real-Time PCR System (Applied Biosystems) following manufacturer instructions. Relative transcript abundance was calculated using the 2−ΔΔCt method, normalizing each target’s cycle threshold (Ct) to the endogenous control gene, ACTB (Mm02619580_g1 VIC). Statistics Specific statistical details for each experiment can be found in the corresponding figure legend including statistical tests used, exact value of n, what n represents, definition of center, and dispersion and precision measures. Error bars for all experiments represent standard error of the mean. A minimum of three experimental replicates were performed for each assay and the specific number of replicates is noted in the corresponding figure and figure legend. Statistical work was performed using Prism 6 software (GraphPad) and significance is indicated on the graphs as follows: ∗ , P ≤ 0.05; ∗∗ , P ≤ 0.01; ∗∗∗ , P ≤ 0.001; ∗∗∗∗ , P ≤ 0.0001; ns, not significant. Funding This work was supported by UTK start-up funds (to A.J.M.), 1R35GM154838 (to A.J.M.), and UT Human Health and Wellness Research Development Program (to A.J.M.). Author Contributions Conceptualization: E.G.T., J.D.B., and A.J.M. Methodology: E.G.T., A.D.W., M.L.H., and A.J.M. Investigation: E.G.T., A.D.W., M.L.H., H.A.H., H.E., B.E.H., E.B., E.C.M., S.R.M., N.M.V. C.C.L., J.M.W., and J.F. Data curation: E.G.T., A.D.W., M.L.H., J.M.W., J.F., and A.J.M. Resources: T.E.S., L.J.C., J.D.B., and A.J.M. Funding acquisition: A.J.M. Project administration: T.E.S., L.J.C., J.D.B., and A.J.M. Supervision: J.F., T.E.S., L.J.C., J.D.B., and A.J.M. Writing-original draft: E.G.T. and A.J.M. Writing-review and editing: E.G.T., A.D.W., M.L.H., H.A.H., H.E., B.E.H., E.B., E.C.M., S.R.M., N.M.V. C.C.L., J.M.W., J.F., T.E.S., L.J.C., J.D.B., and A.J.M. Competing Interests The authors declare no competing interests. Materials availability All data and unique reagents are available upon request to the corresponding author. Acknowledgements We thank Eric Skaar, Megan Kiedrowski, Carolyn Ibberson, and Alexander Horswill for providing bacterial strains. We thank Amit Joshi for providing the confocal microscopes. We also thank all the members of the Monteith and Sparer labs who provided feedback on the project and paper. We thank the individuals who provided blood and the support staff at UTMC who facilitated the process. We thank Trixie TenBarge and Onyx Mitchell for providing emotional support. Funder Information Declared National Institute of General Medical Sciences, https://ror.org/04q48ey07 , 1R35GM154838 References 1. ↵ Berends , E.T. , Horswill , A.R. , Haste , N.M. , Monestier , M. , Nizet , V. , and von Kockritz-Blickwede , M. ( 2010 ). Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps . J Innate Immun 2 , 576 – 586 . doi: 10.1159/000319909 . OpenUrl CrossRef PubMed Web of Science 2. ↵ Brinkmann , V. , Reichard , U. , Goosmann , C. , Fauler , B. , Uhlemann , Y. , Weiss , D.S. , Weinrauch , Y. , and Zychlinsky , A . ( 2004 ). Neutrophil extracellular traps kill bacteria . Science 303 , 1532 – 1535 . doi: 10.1126/science.1092385 . OpenUrl Abstract / FREE Full Text 3. ↵ Pilsczek , F.H. , Salina , D. , Poon , K.K. , Fahey , C. , Yipp , B.G. , Sibley , C.D. , Robbins , S.M. , Green , F.H. , Surette , M.G. , Sugai , M. , et al. ( 2010 ). A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus . J Immunol 185 , 7413 – 7425 . doi: 10.4049/jimmunol.1000675 . OpenUrl CrossRef PubMed 4. ↵ Yost , C.C. , Cody , M.J. , Harris , E.S. , Thornton , N.L. , McInturff , A.M. , Martinez , M.L. , Chandler , N.B. , Rodesch , C.K. , Albertine , K.H. , Petti , C.A. , et al. ( 2009 ). Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates . Blood 113 , 6419 – 6427 . doi: 10.1182/blood-2008-07-171629 . OpenUrl Abstract / FREE Full Text 5. ↵ Yipp , B.G. , Petri , B. , Salina , D. , Jenne , C.N. , Scott , B.N. , Zbytnuik , L.D. , Pittman , K. , Asaduzzaman , M. , Wu , K. , Meijndert , H.C. , et al. ( 2012 ). Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo . Nat Med 18 , 1386 – 1393 . doi: 10.1038/nm.2847 . OpenUrl CrossRef PubMed 6. ↵ Monteith , A.J. , Miller , J.M. , Beavers , W.N. , Maloney , K.N. , Seifert , E.L. , Hajnoczky , G. , and Skaar , E.P . ( 2022 ). Mitochondrial Calcium Uniporter Affects Neutrophil Bactericidal Activity during Staphylococcus aureus Infection . Infect Immun 90 , e0055121 . doi: 10.1128/IAI.00551-21 . OpenUrl CrossRef PubMed 7. ↵ Monteith , A.J. , Miller , J.M. , Maxwell , C.N. , Chazin , W.J. , and Skaar , E.P . ( 2021 ). Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens . Sci Adv 7 , eabj2101. doi: 10.1126/sciadv.abj2101 . OpenUrl CrossRef 8. ↵ Apel , F. , Andreeva , L. , Knackstedt , L.S. , Streeck , R. , Frese , C.K. , Goosmann , C. , Hopfner , K.P. , and Zychlinsky , A . ( 2021 ). The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps . Sci Signal 14 . doi: 10.1126/scisignal.aax7942 . OpenUrl Abstract / FREE Full Text 9. ↵ Garcia-Romo , G.S. , Caielli , S. , Vega , B. , Connolly , J. , Allantaz , F. , Xu , Z. , Punaro , M. , Baisch , J. , Guiducci , C. , Coffman , R.L. , et al. ( 2011 ). Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus . Sci Transl Med 3 , 73r a20 . doi: 10.1126/scitranslmed.3001201 . OpenUrl CrossRef 10. ↵ Lood , C. , Blanco , L.P. , Purmalek , M.M. , Carmona-Rivera , C. , De Ravin , S.S. , Smith , C.K. , Malech , H.L. , Ledbetter , J.A. , Elkon , K.B. , and Kaplan , M.J. ( 2016 ). Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease . Nat Med 22 , 146 – 153 . doi: 10.1038/nm.4027 . OpenUrl CrossRef PubMed 11. ↵ Rother , N. , Pieterse , E. , Lubbers , J. , Hilbrands , L. , and van der Vlag , J . ( 2017 ). Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis . Front Immunol 8 , 1136 . doi: 10.3389/fimmu.2017.01136 . OpenUrl CrossRef 12. ↵ Knight , J.S. , Zhao , W. , Luo , W. , Subramanian , V. , O’Dell , A.A. , Yalavarthi , S. , Hodgin , J.B. , Eitzman , D.T. , Thompson , P.R. , and Kaplan , M.J . ( 2013 ). Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus . J Clin Invest 123 , 2981 – 2993 . doi: 10.1172/JCI67390 . OpenUrl CrossRef PubMed Web of Science 13. ↵ Lande , R. , Ganguly , D. , Facchinetti , V. , Frasca , L. , Conrad , C. , Gregorio , J. , Meller , S. , Chamilos , G. , Sebasigari , R. , Riccieri , V. , et al. ( 2011 ). Neutrophils activate plasmacytoid dendritic cells by releasing self- DNA-peptide complexes in systemic lupus erythematosus . Sci Transl Med 3 , 73r a19 . doi: 10.1126/scitranslmed.3001180 . OpenUrl CrossRef 14. ↵ Carmona-Rivera , C. , Zhao , W. , Yalavarthi , S. , and Kaplan , M.J . ( 2015 ). Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2 . Ann Rheum Dis 74 , 1417 – 1424 . doi: 10.1136/annrheumdis-2013-204837 . OpenUrl Abstract / FREE Full Text 15. Denny , M.F. , Yalavarthi , S. , Zhao , W. , Thacker , S.G. , Anderson , M. , Sandy , A.R. , McCune , W.J. , and Kaplan , M.J . ( 2010 ). A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs . J Immunol 184 , 3284 – 3297 . doi: 10.4049/jimmunol.0902199 . OpenUrl Abstract / FREE Full Text 16. ↵ Villanueva , E. , Yalavarthi , S. , Berthier , C.C. , Hodgin , J.B. , Khandpur , R. , Lin , A.M. , Rubin , C.J. , Zhao , W. , Olsen , S.H. , Klinker , M. , et al. ( 2011 ). Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus . J Immunol 187 , 538 – 552 . doi: 10.4049/jimmunol.1100450 . OpenUrl Abstract / FREE Full Text 17. ↵ Meng , H. , Yalavarthi , S. , Kanthi , Y. , Mazza , L.F. , Elfline , M.A. , Luke , C.E. , Pinsky , D.J. , Henke , P.K. , and Knight , J.S . ( 2017 ). In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis . Arthritis Rheumatol 69 , 655 – 667 . doi: 10.1002/art.39938 . OpenUrl CrossRef PubMed 18. ↵ Yalavarthi , S. , Gould , T.J. , Rao , A.N. , Mazza , L.F. , Morris , A.E. , Nunez-Alvarez , C. , Hernandez-Ramirez , D. , Bockenstedt , P.L. , Liaw , P.C. , Cabral , A.R. , and Knight , J.S . ( 2015 ). Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome . Arthritis Rheumatol 67 , 2990 – 3003 . doi: 10.1002/art.39247 . OpenUrl CrossRef PubMed 19. ↵ Carlucci , P.M. , Purmalek , M.M. , Dey , A.K. , Temesgen-Oyelakin , Y. , Sakhardande , S. , Joshi , A.A. , Lerman , J.B. , Fike , A. , Davis , M. , Chung , J.H. , et al. ( 2018 ). Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus . JCI Insight 3 . doi: 10.1172/jci.insight.99276 . OpenUrl CrossRef PubMed 20. ↵ Tyden , H. , Lood , C. , Gullstrand , B. , Jonsen , A. , Nived , O. , Sturfelt , G. , Truedsson , L. , Ivars , F. , Leanderson , T. , and Bengtsson , A.A . ( 2013 ). Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus . Rheumatology (Oxford ) 52 , 2048 – 2055 . doi: 10.1093/rheumatology/ket263 . OpenUrl CrossRef PubMed Web of Science 21. ↵ Kenny , E.F. , Raupach , B. , Abu Abed , U. , Brinkmann , V. , and Zychlinsky , A . ( 2019 ). Dnase1-deficient mice spontaneously develop a systemic lupus erythematosus-like disease . Eur J Immunol 49 , 590 – 599 . doi: 10.1002/eji.201847875 . OpenUrl CrossRef PubMed 22. Sisirak , V. , Sally , B. , D’Agati , V. , Martinez-Ortiz , W. , Ozcakar , Z.B. , David , J. , Rashidfarrokhi , A. , Yeste , A. , Panea , C. , Chida , A.S. , et al. ( 2016 ). Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity . Cell 166 , 88 – 101 . doi: 10.1016/j.cell.2016.05.034 . OpenUrl CrossRef PubMed 23. ↵ Wilber , A. , O’Connor , T.P. , Lu , M.L. , Karimi , A. , and Schneider , M.C . ( 2003 ). Dnase1l3 deficiency in lupus- prone MRL and NZB/W F1 mice . Clin Exp Immunol 134 , 46 – 52 . doi: 10.1046/j.1365-2249.2003.02267.x . OpenUrl CrossRef PubMed Web of Science 24. ↵ Hanayama , R. , Tanaka , M. , Miwa , K. , Shinohara , A. , Iwamatsu , A. , and Nagata , S . ( 2002 ). Identification of a factor that links apoptotic cells to phagocytes . Nature 417 , 182 – 187 . doi: 10.1038/417182a . OpenUrl CrossRef PubMed Web of Science 25. ↵ Monteith , A.J. , Kang , S. , Scott , E. , Hillman , K. , Rajfur , Z. , Jacobson , K. , Costello , M.J. , and Vilen , B.J . ( 2016 ). Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus . Proc Natl Acad Sci U S A 113 , E2142 – 2151 . doi: 10.1073/pnas.1513943113 . OpenUrl Abstract / FREE Full Text 26. ↵ Monteith , A.J. , Vincent , H.A. , Kang , S. , Li , P. , Claiborne , T.M. , Rajfur , Z. , Jacobson , K. , Moorman , N.J. , and Vilen , B.J . ( 2018 ). mTORC2 Activity Disrupts Lysosome Acidification in Systemic Lupus Erythematosus by Impairing Caspase-1 Cleavage of Rab39a . J Immunol 201 , 371 – 382 . doi: 10.4049/jimmunol.1701712 . OpenUrl Abstract / FREE Full Text 27. ↵ Caielli , S. , Athale , S. , Domic , B. , Murat , E. , Chandra , M. , Banchereau , R. , Baisch , J. , Phelps , K. , Clayton , S. , Gong , M. , et al. ( 2016 ). Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus . J Exp Med 213 , 697 – 713 . doi: 10.1084/jem.20151876 . OpenUrl Abstract / FREE Full Text 28. Kraaij , T. , Kamerling , S.W.A. , de Rooij , E.N.M. , van Daele , P.L.A. , Bredewold , O.W. , Bakker , J.A. , Bajema , I.M. , Scherer , H.U. , Toes , R.E.M. , Huizinga , T.J.W. , et al. ( 2018 ). The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus . J Autoimmun 91 , 45 – 54 . doi: 10.1016/j.jaut.2018.03.003 . OpenUrl CrossRef PubMed 29. ↵ Pieterse , E. , Rother , N. , Garsen , M. , Hofstra , J.M. , Satchell , S.C. , Hoffmann , M. , Loeven , M.A. , Knaapen , H.K. , van der Heijden , O.W.H. , Berden , J.H.M. , et al. ( 2017 ). Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition . Arterioscler Thromb Vasc Biol 37 , 1371 – 1379 . doi: 10.1161/ATVBAHA.117.309002 . OpenUrl Abstract / FREE Full Text 30. ↵ Fuchs , T.A. , Abed , U. , Goosmann , C. , Hurwitz , R. , Schulze , I. , Wahn , V. , Weinrauch , Y. , Brinkmann , V. , and Zychlinsky , A . ( 2007 ). Novel cell death program leads to neutrophil extracellular traps . J Cell Biol 176 , 231 – 241 . doi: 10.1083/jcb.200606027 . OpenUrl Abstract / FREE Full Text 31. ↵ Bianchi , M. , Hakkim , A. , Brinkmann , V. , Siler , U. , Seger , R.A. , Zychlinsky , A. , and Reichenbach , J . ( 2009 ). Restoration of NET formation by gene therapy in CGD controls aspergillosis . Blood 114 , 2619 – 2622 . doi: 10.1182/blood-2009-05-221606 . OpenUrl Abstract / FREE Full Text 32. ↵ Abuaita , B.H. , Sule , G.J. , Schultz , T.L. , Gao , F. , Knight , J.S. , and O’Riordan , M.X . ( 2021 ). The IRE1alpha Stress Signaling Axis Is a Key Regulator of Neutrophil Antimicrobial Effector Function . J Immunol 207 , 210 – 220 . doi: 10.4049/jimmunol.2001321 . OpenUrl Abstract / FREE Full Text 33. ↵ Mazzoleni , V. , Zimmermann , K. , Smirnova , A. , Tarassov , I. , and Prevost , G . ( 2021 ). Staphylococcus aureus Panton-Valentine Leukocidin triggers an alternative NETosis process targeting mitochondria . FASEB J 35 , e21167 . doi: 10.1096/fj.201902981R . OpenUrl CrossRef 34. ↵ Wise , A.D. , TenBarge , E.G. , Mendonca , J.D.C. , Mennen , E.C. , McDaniel , S.R. , Reber , C.P. , Holder , B.E. , Bunch , M.L. , Belevska , E. , Marshall , M.G. , et al. ( 2025 ). Mitochondria sense bacterial lactate and drive release of neutrophil extracellular traps . Cell Host Microbe . doi: 10.1016/j.chom.2025.02.003 . OpenUrl CrossRef 35. ↵ Sule , G. , Abuaita , B.H. , Steffes , P.A. , Fernandes , A.T. , Estes , S.K. , Dobry , C. , Pandian , D. , Gudjonsson , J.E. , Kahlenberg , J.M. , O’Riordan , M.X. , and Knight , J.S . ( 2021 ). Endoplasmic reticulum stress sensor IRE1alpha propels neutrophil hyperactivity in lupus . J Clin Invest 131 . doi: 10.1172/JCI137866 . OpenUrl CrossRef PubMed 36. ↵ Chowdhury , C.S. , Kinsella , R.L. , McNehlan , M.E. , Naik , S.K. , Lane , D.S. , Talukdar , P. , Smirnov , A. , Dubey , N. , Rankin , A.N. , McKee , S.R. , et al. ( 2024 ). Type I IFN-mediated NET release promotes Mycobacterium tuberculosis replication and is associated with granuloma caseation . Cell Host Microbe 32 , 2092 – 2111 e2097. doi: 10.1016/j.chom.2024.11.008 . OpenUrl CrossRef PubMed 37. ↵ Li , P. , Li , M. , Lindberg , M.R. , Kennett , M.J. , Xiong , N. , and Wang , Y . ( 2010 ). PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps . J Exp Med 207 , 1853 – 1862 . doi: 10.1084/jem.20100239 . OpenUrl Abstract / FREE Full Text 38. ↵ Monteith , A.J. , Miller , J.M. , Williams , J.M. , Voss , K. , Rathmell , J.C. , Crofford , L.J. , and Skaar , E.P . ( 2022 ). Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating Staphylococcus aureus . J Immunol 208 , 454 – 463 . doi: 10.4049/jimmunol.2100752 . OpenUrl Abstract / FREE Full Text 39. ↵ Schuster , D.P. , Brody , S.L. , Zhou , Z. , Bernstein , M. , Arch , R. , Link , D. , and Mueckler , M . ( 2007 ). Regulation of lipopolysaccharide-induced increases in neutrophil glucose uptake . Am J Physiol Lung Cell Mol Physiol 292 , L845 – 851 . doi: 10.1152/ajplung.00350.2006 . OpenUrl CrossRef PubMed Web of Science 40. Azevedo , E.P. , Rochael , N.C. , Guimarães-Costa , A.B. , de Souza-Vieira , T.S. , Ganilho , J. , Saraiva , E.M. , Palhano , F.L. , and Foguel , D. ( 2015 ). A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril- and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation . J Biol Chem 290 , 22174 – 22183 . doi: 10.1074/jbc.M115.640094 . OpenUrl Abstract / FREE Full Text 41. Borregaard , N. , and Herlin , T . ( 1982 ). Energy metabolism of human neutrophils during phagocytosis . J Clin Invest 70 , 550 – 557 . doi: 10.1172/jci110647 . OpenUrl CrossRef PubMed Web of Science 42. Rodríguez-Espinosa , O. , Rojas-Espinosa , O. , Moreno-Altamirano , M.M. , López-Villegas , E.O. , and Sánchez-García , F.J . ( 2015 ). Metabolic requirements for neutrophil extracellular traps formation . Immunology 145 , 213 – 224 . doi: 10.1111/imm.12437 . OpenUrl CrossRef PubMed 43. ↵ Sbarra , A.J. , and Karnovsky , M.L . ( 1959 ). The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes . J Biol Chem 234 , 1355 – 1362 . OpenUrl FREE Full Text 44. ↵ Fossati , G. , Moulding , D.A. , Spiller , D.G. , Moots , R.J. , White , M.R. , and Edwards , S.W . ( 2003 ). The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis . J Immunol 170 , 1964 – 1972 . doi: 10.4049/jimmunol.170.4.1964 . OpenUrl Abstract / FREE Full Text 45. ↵ van Raam , B.J. , Sluiter , W. , de Wit , E. , Roos , D. , Verhoeven , A.J. , and Kuijpers , T.W. ( 2008 ). Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation . PLoS One 3 , e2013 . doi: 10.1371/journal.pone.0002013 . OpenUrl CrossRef PubMed 46. ↵ Chen , M.J. , Tseng , H.M. , Huang , Y.L. , Hsu , W.N. , Yeh , K.W. , Wu , T.L. , See , L.C. , and Huang , J.L . ( 2008 ). Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up . Rheumatology (Oxford ) 47 , 1352 – 1357 . doi: 10.1093/rheumatology/ken196 . OpenUrl CrossRef PubMed Web of Science 47. Conti , F. , Ceccarelli , F. , Iaiani , G. , Perricone , C. , Giordano , A. , Amori , L. , Miranda , F. , Massaro , L. , Pacucci , V.A. , Truglia , S. , et al. ( 2016 ). Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus . Arthritis Res Ther 18 , 177 . doi: 10.1186/s13075 - 016-1079-x. OpenUrl CrossRef 48. Hellmann , D.B. , Petri , M. , and Whiting-O’Keefe , Q . ( 1987 ). Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms . Medicine (Baltimore ) 66 , 341 – 348 . doi: 10.1097/00005792-198709000-00002 . OpenUrl CrossRef PubMed Web of Science 49. ↵ Ruiz-Irastorza , G. , Olivares , N. , Ruiz-Arruza , I. , Martinez-Berriotxoa , A. , Egurbide , M.V. , and Aguirre , C . ( 2009 ). Predictors of major infections in systemic lupus erythematosus . Arthritis Res Ther 11 , R109 . doi: 10.1186/ar2764 . OpenUrl CrossRef PubMed 50. ↵ Niu , X. , Chen , Y.J. , Crawford , P.A. , and Patti , G.J . ( 2018 ). Transport-exclusion pharmacology to localize lactate dehydrogenase activity within cells . Cancer Metab 6 , 19 . doi: 10.1186/s40170-018-0192-5 . OpenUrl CrossRef PubMed 51. Wu , H. , Wang , Y. , Ying , M. , Jin , C. , Li , J. , and Hu , X . ( 2021 ). Lactate dehydrogenases amplify reactive oxygen species in cancer cells in response to oxidative stimuli . Signal Transduct Target Ther 6 , 242 . doi: 10.1038/s41392-021-00595-3 . OpenUrl CrossRef PubMed 52. ↵ Young , A. , Oldford , C. , and Mailloux , R.J . ( 2020 ). Lactate dehydrogenase supports lactate oxidation in mitochondria isolated from different mouse tissues . Redox Biol 28 , 101339 . doi: 10.1016/j.redox.2019.101339 . OpenUrl CrossRef 53. ↵ Andrews , B.S. , Eisenberg , R.A. , Theofilopoulos , A.N. , Izui , S. , Wilson , C.B. , McConahey , P.J. , Murphy , E.D. , Roths , J.B. , and Dixon , F.J . ( 1978 ). Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains . J Exp Med 148 , 1198 – 1215 . doi: 10.1084/jem.148.5.1198 . OpenUrl Abstract / FREE Full Text 54. ↵ Greene , T.T. , Jo , Y. , Chiale , C. , Macal , M. , Fang , Z. , Khatri , F.S. , Codrington , A.L. , Kazane , K.R. , Akbulut , E. , Swaminathan , S. , et al. ( 2025 ). Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN- I production following viral infection . Nat Commun 16 , 1460 . doi: 10.1038/s41467-025-56603-5 . OpenUrl CrossRef 55. ↵ Viglianti , G.A. , Lau , C.M. , Hanley , T.M. , Miko , B.A. , Shlomchik , M.J. , and Marshak-Rothstein , A . ( 2003 ). Activation of autoreactive B cells by CpG dsDNA . Immunity 19 , 837 – 847 . doi: 10.1016/s1074-7613(03)00323-6 . OpenUrl CrossRef PubMed Web of Science 56. ↵ Lau , C.M. , Broughton , C. , Tabor , A.S. , Akira , S. , Flavell , R.A. , Mamula , M.J. , Christensen , S.R. , Shlomchik , M.J. , Viglianti , G.A. , Rifkin , I.R. , and Marshak-Rothstein , A . ( 2005 ). RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement . J Exp Med 202 , 1171 – 1177 . doi: 10.1084/jem.20050630 . OpenUrl Abstract / FREE Full Text 57. ↵ Kuznik , A. , Bencina , M. , Svajger , U. , Jeras , M. , Rozman , B. , and Jerala , R . ( 2011 ). Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines . J Immunol 186 , 4794 – 4804 . doi: 10.4049/jimmunol.1000702 . OpenUrl Abstract / FREE Full Text 58. ↵ Kenny , E.F. , Herzig , A. , Kruger , R. , Muth , A. , Mondal , S. , Thompson , P.R. , Brinkmann , V. , Bernuth , H.V. , and Zychlinsky , A . ( 2017 ). Diverse stimuli engage different neutrophil extracellular trap pathways . Elife 6 . doi: 10.7554/eLife.24437 . OpenUrl CrossRef PubMed 59. ↵ Suttorp , N. , and Habben , E . ( 1988 ). Effect of staphylococcal alpha-toxin on intracellular Ca2+ in polymorphonuclear leukocytes . Infect Immun 56 , 2228 – 2234 . doi: 10.1128/iai.56.9.2228-2234.1988 . OpenUrl Abstract / FREE Full Text 60. ↵ Yang , F. , Suo , M. , Weli , H. , Wong , M. , Junidi , A. , Cummings , C. , Johnson , R. , Mallory , K. , Liu , A.Y. , Greenberg , Z.J. , et al. ( 2023 ). Staphylococcus aureus alpha-toxin impairs early neutrophil localization via electrogenic disruption of store-operated calcium entry . Cell Rep 42 , 113394 . doi: 10.1016/j.celrep.2023.113394 . OpenUrl CrossRef 61. ↵ Becker , R.E. , Berube , B.J. , Sampedro , G.R. , DeDent , A.C. , and Bubeck Wardenburg , J . ( 2014 ). Tissue- specific patterning of host innate immune responses by Staphylococcus aureus alpha-toxin . J Innate Immun 6 , 619 – 631 . doi: 10.1159/000360006 . OpenUrl CrossRef 62. Gemmell , C.G. , Peterson , P.K. , Schmeling , D.J. , and Quie , P.G . ( 1982 ). Effect of staphylococcal alpha-toxin on phagocytosis of staphylococci by human polymorphonuclear leukocytes . Infect Immun 38 , 975 – 980 . doi: 10.1128/iai.38.3.975-980.1982 . OpenUrl Abstract / FREE Full Text 63. ↵ Suttorp , N. , Seeger , W. , Zucker-Reimann , J. , Roka , L. , and Bhakdi , S . ( 1987 ). Mechanism of leukotriene generation in polymorphonuclear leukocytes by staphylococcal alpha-toxin . Infect Immun 55 , 104 – 110 . doi: 10.1128/iai.55.1.104-110.1987 . OpenUrl Abstract / FREE Full Text 64. ↵ Schmeling , D.J. , Gemmell , C.G. , Craddock , P.R. , Quie , P.G. , and Peterson , P.K . ( 1981 ). Effect of staphylococcal alpha-toxin on neutrophil migration and adhesiveness . Inflammation 5 , 313 – 322 . doi: 10.1007/BF00911095 . OpenUrl CrossRef PubMed 65. ↵ Goldstein , I.M. , Horn , J.K. , Kaplan , H.B. , and Weissmann , G . ( 1974 ). Calcium-induced lysozyme secretion from human polymorphonuclear leukocytes . Biochem Biophys Res Commun 60 , 807 – 812 . doi: 10.1016/0006-291x(74)90312-x . OpenUrl CrossRef PubMed Web of Science 66. Lew , P.D. , Monod , A. , Waldvogel , F.A. , Dewald , B. , Baggiolini , M. , and Pozzan , T . ( 1986 ). Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils . J Cell Biol 102 , 2197 – 2204 . doi: 10.1083/jcb.102.6.2197 . OpenUrl Abstract / FREE Full Text 67. ↵ Sengelov , H. , Kjeldsen , L. , and Borregaard , N . ( 1993 ). Control of exocytosis in early neutrophil activation . J Immunol 150 , 1535 – 1543 . OpenUrl Abstract 68. ↵ Kehl-Fie , T.E. , Zhang , Y. , Moore , J.L. , Farrand , A.J. , Hood , M.I. , Rathi , S. , Chazin , W.J. , Caprioli , R.M. , and Skaar , E.P . ( 2013 ). MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese . Infect Immun 81 , 3395 – 3405 . doi: 10.1128/IAI.00420-13 . OpenUrl Abstract / FREE Full Text 69. ↵ Corbin , B.D. , Seeley , E.H. , Raab , A. , Feldmann , J. , Miller , M.R. , Torres , V.J. , Anderson , K.L. , Dattilo , B.M. , Dunman , P.M. , Gerads , R. , et al. ( 2008 ). Metal chelation and inhibition of bacterial growth in tissue abscesses . Science 319 , 962 – 965 . doi: 10.1126/science.1152449 . OpenUrl Abstract / FREE Full Text 70. ↵ Jhelum , H. , Cerina , D. , Harbort , C.J. , Lindner , A. , Hanitsch , L.G. , Leistner , R. , Schroder , J.T. , von Bernuth , H. , Stegemann , M.S. , Schurmann , M. , et al. ( 2024 ). Panton-Valentine leukocidin-induced neutrophil extracellular traps lack antimicrobial activity and are readily induced in patients with recurrent PVL + - Staphylococcus aureus infections . J Leukoc Biol 115 , 222 – 234 . doi: 10.1093/jleuko/qiad137 . OpenUrl CrossRef 71. ↵ Li , Y. , Lee , P.Y. , Sobel , E.S. , Narain , S. , Satoh , M. , Segal , M.S. , Reeves , W.H. , and Richards , H.B . ( 2009 ). Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus . Arthritis Res Ther 11 , R6 . doi: 10.1186/ar2590 . OpenUrl CrossRef 72. Hu , J.L. , Li , G. , Zhou , D.X. , Zou , Y.X. , Zhu , Z.S. , Xu , R.X. , Jiang , X.D. , and Zeng , Y.J . ( 2009 ). Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease . Cell Mol Neurobiol 29 , 81 – 85 . doi: 10.1007/s10571-008-9299-5 . OpenUrl CrossRef PubMed 73. Fries , L.F. , Mullins , W.W. , Cho , K.R. , Plotz , P.H. , and Frank , M.M . ( 1984 ). Monocyte receptors for the Fc portion of IgG are increased in systemic lupus erythematosus . J Immunol 132 , 695 – 700 . OpenUrl Abstract / FREE Full Text 74. ↵ Ballantine , L. , Midgley , A. , Harris , D. , Richards , E. , Burgess , S. , and Beresford , M.W . ( 2015 ). Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus . Pediatr Rheumatol Online J 13 , 10 . doi: 10.1186/s12969-015-0007-y . OpenUrl CrossRef PubMed 75. ↵ Pickering , M.C. , Botto , M. , Taylor , P.R. , Lachmann , P.J. , and Walport , M.J . ( 2000 ). Systemic lupus erythematosus, complement deficiency, and apoptosis . Adv Immunol 76 , 227 – 324 . doi: 10.1016/s0065-2776(01)76021-x . OpenUrl CrossRef PubMed Web of Science 76. ↵ Lopez-Lopez , L. , Nieves-Plaza , M. , Castro Mdel , R. , Font , Y.M. , Torres-Ramos , C.A. , Vila , L.M. , and Ayala-Pena , S . ( 2014 ). Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus . Lupus 23 , 1133 – 1141 . doi: 10.1177/0961203314537697 . OpenUrl CrossRef PubMed 77. Caza , T.N. , Fernandez , D.R. , Talaber , G. , Oaks , Z. , Haas , M. , Madaio , M.P. , Lai , Z.W. , Miklossy , G. , Singh , R.R. , Chudakov , D.M. , et al. ( 2014 ). HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE . Ann Rheum Dis 73 , 1888 – 1897 . doi: 10.1136/annrheumdis-2013-203794 . OpenUrl Abstract / FREE Full Text 78. Buskiewicz , I.A. , Montgomery , T. , Yasewicz , E.C. , Huber , S.A. , Murphy , M.P. , Hartley , R.C. , Kelly , R. , Crow , M.K. , Perl , A. , Budd , R.C. , and Koenig , A . ( 2016 ). Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus . Sci Signal 9 , ra115. doi: 10.1126/scisignal.aaf1933 . OpenUrl Abstract / FREE Full Text 79. ↵ Blanco , L.P. , Pedersen , H.L. , Wang , X. , Lightfoot , Y.L. , Seto , N. , Carmona-Rivera , C. , Yu , Z.X. , Hoffmann , V. , Yuen , P.S.T. , and Kaplan , M.J . ( 2020 ). Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone . Arthritis Rheumatol 72 , 454 – 464 . doi: 10.1002/art.41128 . OpenUrl CrossRef PubMed 80. ↵ Fey , P.D. , Endres , J.L. , Yajjala , V.K. , Widhelm , T.J. , Boissy , R.J. , Bose , J.L. , and Bayles , K.W . ( 2013 ). A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes . mBio 4 , e00537 – 00512 . doi: 10.1128/mBio.00537-12 . OpenUrl CrossRef PubMed 81. ↵ Olson , M.E. , Nygaard , T.K. , Ackermann , L. , Watkins , R.L. , Zurek , O.W. , Pallister , K.B. , Griffith , S. , Kiedrowski , M.R. , Flack , C.E. , Kavanaugh , J.S. , et al. ( 2013 ). Staphylococcus aureus nuclease is an SaeRS- dependent virulence factor . Infect Immun 81 , 1316 – 1324 . doi: 10.1128/IAI.01242-12 . OpenUrl Abstract / FREE Full Text View the discussion thread. Back to top Previous Next Posted October 07, 2025. Download PDF Supplementary Material Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus Eden G. TenBarge , Ashley D. Wise , Morgan L. Hetzel , Helene A. Hoover , Helia Esfandiari , Bailey E. Holder , Eva Belevska , Ellie C. Mennen , Sarah R. McDaniel , Nicole M. Vaccaro , Courtney C. Lucca , Jonathan M. Williams , Jennifer Ferris , Timothy E. Sparer , Leslie J. Crofford , Jeffry D. Bieber , Andrew J. Monteith bioRxiv 2025.10.07.680928; doi: https://doi.org/10.1101/2025.10.07.680928 Share This Article: Copy Citation Tools A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus Eden G. TenBarge , Ashley D. Wise , Morgan L. Hetzel , Helene A. Hoover , Helia Esfandiari , Bailey E. Holder , Eva Belevska , Ellie C. Mennen , Sarah R. McDaniel , Nicole M. Vaccaro , Courtney C. Lucca , Jonathan M. Williams , Jennifer Ferris , Timothy E. Sparer , Leslie J. Crofford , Jeffry D. Bieber , Andrew J. Monteith bioRxiv 2025.10.07.680928; doi: https://doi.org/10.1101/2025.10.07.680928 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Immunology Subject Areas All Articles Animal Behavior and Cognition (7618) Biochemistry (17633) Bioengineering (13856) Bioinformatics (41841) Biophysics (21399) Cancer Biology (18529) Cell Biology (25422) Clinical Trials (138) Developmental Biology (13352) Ecology (19860) Epidemiology (2067) Evolutionary Biology (24282) Genetics (15582) Genomics (22462) Immunology (17700) Microbiology (40295) Molecular Biology (17140) Neuroscience (88419) Paleontology (666) Pathology (2823) Pharmacology and Toxicology (4813) Physiology (7632) Plant Biology (15107) Scientific Communication and Education (2042) Synthetic Biology (4284) Systems Biology (9808) Zoology (2267)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00